Dorton Katina
SEC insider (Form 3/4/5 filer). CIK 0001617541. Director at Keenova Therapeutics plc (NONE) and 3 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in CAMBRIDGE, MA.
Companies Dorton Katina has filed insider reports for
- Keenova Therapeutics plc (NONE): Director
- Fulcrum Therapeutics, Inc. (FULC): Director
- Prelude Therapeutics Inc (PRLD): Director
- TScan Therapeutics, Inc. (TCRX): Director
Dorton Katina
CIK: 0001617541
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jul 15, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
4.4K shares- - Jun 30, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
32K shares- - Jun 9, 2026PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
38K shares- - Jun 2, 2026No ticker
Keenova Therapeutics plc
ExerciseDirect4.9K shares- - May 20, 2026TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Feb 23, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
4K shares- - Jan 1, 2026No ticker
Keenova Therapeutics plc
DispositionDirectRestricted Stock Units
1.5K shares- - Jan 1, 2026No ticker
Keenova Therapeutics plc
Tax PaymentDirect513 shares- - Jan 1, 2026No ticker
Keenova Therapeutics plc
ExerciseDirect1.8K shares- - Oct 17, 2025PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
76K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 4,406 | - | - | Direct |
| Jun 30, 2026 |  FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 32,000 | - | - | Direct |
| Jun 9, 2026 |  PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Jun 2, 2026 | No ticker Keenova Therapeutics plc | Exercise | 4,882 | - | $0 | Direct |
| May 20, 2026 |  TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Feb 23, 2026 | No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 3,984 | - | - | Direct |
| Jan 1, 2026 | No ticker Keenova Therapeutics plc | Disposition Restricted Stock Units | 1,480 | - | - | Direct |
| Jan 1, 2026 | No ticker Keenova Therapeutics plc | Tax Payment | 513 | - | $0 | Direct |
| Jan 1, 2026 | No ticker Keenova Therapeutics plc | Exercise | 1,808 | - | $0 | Direct |
| Oct 17, 2025 | PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 76,000 | - | - | Direct |
1-10 of 17 transactions